Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

A Novel Angiotensin-(1-7)-glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation Related Memory Dysfunction.

Hay M, Polt R, Heien ML, Vanderah TW, Largen-Milnes TM, Rodgers KE, Falk T, Bartlett MJ, Doyle K, Konhilas J.

J Pharmacol Exp Ther. 2019 Feb 1. pii: jpet.118.254854. doi: 10.1124/jpet.118.254854. [Epub ahead of print]

2.

Long-Term Administration of Angiotensin (1-7) to db/db Mice Reduces Oxidative Stress Damage in the Kidneys and Prevents Renal Dysfunction.

Papinska AM, Rodgers KE.

Oxid Med Cell Longev. 2018 Oct 23;2018:1841046. doi: 10.1155/2018/1841046. eCollection 2018.

3.

Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion.

Nation DA, Tan A, Dutt S, McIntosh EC, Yew B, Ho JK, Blanken AE, Jang JY, Rodgers KE, Gaubert A.

J Alzheimers Dis. 2018;61(1):91-101. doi: 10.3233/JAD-170587.

4.

Renin Angiotensin system-modifying therapies are associated with improved pulmonary health.

Soto M, Bang SI, McCombs J, Rodgers KE.

Clin Diabetes Endocrinol. 2017 Jun 28;3:6. doi: 10.1186/s40842-017-0044-1. eCollection 2017.

5.

Development of a guinea pig cutaneous radiation injury model using low penetrating X-rays.

Rodgers KE, Tan A, Kim L, Espinoza T, Meeks C, Johnston W, Maulhardt H, Donald M, Hill C, diZerega GS.

Int J Radiat Biol. 2016 Aug;92(8):434-43. doi: 10.1080/09553002.2016.1186302. Epub 2016 Jun 3.

PMID:
27258737
6.

NorLeu3A(1-7) Accelerates Clear Corneal Full Thickness Wound Healing.

Abdallah WF, Louie SG, Zhang Y, Rodgers KE, Sivok E, S diZerega G, Humayun MS.

Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2187-94. doi: 10.1167/iovs.15-18515.

PMID:
27116546
7.
8.

Chronic ethanol exposure combined with high fat diet up-regulates P2X7 receptors that parallels neuroinflammation and neuronal loss in C57BL/6J mice.

Asatryan L, Khoja S, Rodgers KE, Alkana RL, Tsukamoto H, Davies DL.

J Neuroimmunol. 2015 Aug 15;285:169-79. doi: 10.1016/j.jneuroim.2015.06.007. Epub 2015 Jun 20.

9.

Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder.

Yardley MM, Huynh N, Rodgers KE, Alkana RL, Davies DL.

Alcohol. 2015 Sep;49(6):553-9. doi: 10.1016/j.alcohol.2015.03.006. Epub 2015 May 29.

10.

Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice.

Papinska AM, Mordwinkin NM, Meeks CJ, Jadhav SS, Rodgers KE.

Br J Pharmacol. 2015 Sep;172(18):4443-4453. doi: 10.1111/bph.13225. Epub 2015 Jul 30.

11.

Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.

Irwin RW, Solinsky CM, Loya CM, Salituro FG, Rodgers KE, Bauer G, Rogawski MA, Brinton RD.

PLoS One. 2015 Jun 3;10(6):e0128313. doi: 10.1371/journal.pone.0128313. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0132210.

12.

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers.

Rodgers KE, Bolton LL, Verco S, diZerega GS.

Adv Wound Care (New Rochelle). 2015 Jun 1;4(6):339-345. Review.

13.

Effect of combined radiation injury on cell death and inflammation in skin.

Jadhav SS, Meeks CJ, Mordwinkin NM, Espinoza TB, Louie SG, diZerega GS, Rodgers KE.

Apoptosis. 2015 Jul;20(7):892-906. doi: 10.1007/s10495-015-1116-2.

PMID:
25772546
14.

Angiotensin 1 - 7 stimulation of platelet recovery.

Rodgers KE, Peterson KJ, Maulhardt HA, diZerega GS.

Expert Opin Investig Drugs. 2014 Apr;23(4):551-9. doi: 10.1517/13543784.2014.891015. Epub 2014 Feb 20. Review.

PMID:
24555825
15.

Contribution of the Local RAS to Hematopoietic Function: A Novel Therapeutic Target.

Rodgers KE, Dizerega GS.

Front Endocrinol (Lausanne). 2013 Oct 23;4:157. doi: 10.3389/fendo.2013.00157. Review.

16.

Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery.

Rodgers KE, Espinoza TB, Roda N, Meeks CJ, diZerega GS.

Cancer Chemother Pharmacol. 2013 Dec;72(6):1235-45. doi: 10.1007/s00280-013-2312-9. Epub 2013 Oct 5.

PMID:
24091850
17.

Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy.

Pham H, Schwartz BM, Delmore JE, Reed E, Cruickshank S, Drummond L, Rodgers KE, Peterson KJ, diZerega GS.

Cancer Chemother Pharmacol. 2013 Apr;71(4):965-72. doi: 10.1007/s00280-013-2089-x. Epub 2013 Jan 31.

PMID:
23370663
18.

Effects of combined radiation and burn injury on the renin-angiotensin system.

Jadhav SS, Sharma N, Meeks CJ, Mordwinkin NM, Espinoza TB, Roda NR, DiZerega GS, Hill CK, Louie SG, Rodgers KE.

Wound Repair Regen. 2013 Jan-Feb;21(1):131-40. doi: 10.1111/j.1524-475X.2012.00867.x. Epub 2012 Dec 11.

19.

Immunotoxicology: fifty years of global scientific progress.

McKarns SC, Kerkvliet NI, Dean JH, Bonn MB, Cohen MD, Franko J, Laiosa MD, Lawrence BP, Luebke RW, Luster MI, Miller PG, Palmer RK, Pfau JC, Raman P, Regal JF, Rodgers KE, Schondelmeyer RS, Zhang X, Burns-Naas LA.

J Immunotoxicol. 2012 Oct-Dec;9(4):339-40. doi: 10.3109/1547691X.2012.658530. Epub 2012 Oct 19.

PMID:
23078377
20.

Alteration of endothelial function markers in women with gestational diabetes and their fetuses.

Mordwinkin NM, Ouzounian JG, Yedigarova L, Montoro MN, Louie SG, Rodgers KE.

J Matern Fetal Neonatal Med. 2013 Mar;26(5):507-12. doi: 10.3109/14767058.2012.736564. Epub 2012 Nov 9.

21.

NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial.

Balingit PP, Armstrong DG, Reyzelman AM, Bolton L, Verco SJ, Rodgers KE, Nigh KA, diZerega GS.

Wound Repair Regen. 2012 Jul-Aug;20(4):482-90. doi: 10.1111/j.1524-475X.2012.00804.x. Epub 2012 Jun 7.

22.

Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow.

Mordwinkin NM, Meeks CJ, Jadhav SS, Espinoza T, Roda N, diZerega GS, Louie SG, Rodgers KE.

Endocrinology. 2012 May;153(5):2189-97. doi: 10.1210/en.2011-2031. Epub 2012 Mar 20.

23.

Accelerated hematopoietic recovery with angiotensin-(1-7) after total body radiation.

Rodgers KE, Espinoza T, Roda N, Meeks CJ, Hill C, Louie SG, Dizerega GS.

Int J Radiat Biol. 2012 Jun;88(6):466-76. doi: 10.3109/09553002.2012.676228. Epub 2012 Apr 30.

PMID:
22433112
24.

Toxicological and toxicokinetic analysis of angiotensin (1-7) in two species.

Mordwinkin NM, Russell JR, Burke AS, Dizerega GS, Louie SG, Rodgers KE.

J Pharm Sci. 2012 Jan;101(1):373-80. doi: 10.1002/jps.22730. Epub 2011 Aug 19.

25.

Spontaneous age-related neurite branching in Caenorhabditis elegans.

Tank EM, Rodgers KE, Kenyon C.

J Neurosci. 2011 Jun 22;31(25):9279-88. doi: 10.1523/JNEUROSCI.6606-10.2011.

26.

Two-component polyethylene glycol surgical sealant influence on intraperitoneal infection in a refined rodent model.

Rodgers KE, Burleson FG, Burleson GR, Wolfsegger MJ, Lewis KM, Redl H.

Am J Obstet Gynecol. 2010 Nov;203(5):494.e1-6. doi: 10.1016/j.ajog.2010.06.056. Epub 2010 Sep 1.

PMID:
20810099
27.

Tranilast: a pharmaceutical candidate for reduction of adhesions using a novel approach.

Petrilli J, Wadsworth S, Cooper K, Rodgers KE, Siekierka J, diZerega GS.

Semin Reprod Med. 2008 Jul;26(4):341-8. doi: 10.1055/s-0028-1082392. Review.

PMID:
18756411
28.

Reduction of post-surgical adhesion formation with tranilast.

Cooper K, Young J, Wadsworth S, Cui H, diZerega GS, Rodgers KE.

J Surg Res. 2007 Aug;141(2):153-61. Epub 2007 Jun 8.

PMID:
17560610
29.

A modern biomaterial for adhesion prevention.

diZerega GS, Cortese S, Rodgers KE, Block KM, Falcone SJ, Juarez TG, Berg R.

J Biomed Mater Res B Appl Biomater. 2007 Apr;81(1):239-50. Review.

PMID:
16969823
30.

Expression of intracellular filament, collagen, and collagenase genes in diabetic and normal skin after injury.

Rodgers KE, Ellefson DD, Espinoza T, Hsu YH, diZerega GS, Mehrian-Shai R.

Wound Repair Regen. 2006 May-Jun;14(3):298-305.

PMID:
16808808
31.

Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer.

Rodgers KE, Oliver J, diZerega GS.

Cancer Chemother Pharmacol. 2006 May;57(5):559-68. Epub 2005 Aug 12.

PMID:
16096787
32.

Technology evaluation: Chrysalin (Orthologic).

Rodgers KE.

Curr Opin Mol Ther. 2005 Jun;7(3):264-72. Review.

PMID:
15977425
33.

Effect of NorLeu3-A(1-7) on scar formation over time after full-thickness incision injury in the rat.

Rodgers KE, Ellefson DD, Espinoza T, Roda N, Maldonado S, Dizerega GS.

Wound Repair Regen. 2005 May-Jun;13(3):309-17.

PMID:
15953051
34.

Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice.

Rodgers KE, Roda N, Felix JE, Espinoza T, Maldonado S, diZerega G.

Exp Dermatol. 2003 Dec;12(6):784-90.

PMID:
14714558
35.

Reduction of epidural fibrosis in lumbar surgery with Oxiplex adhesion barriers of carboxymethylcellulose and polyethylene oxide.

Rodgers KE, Robertson JT, Espinoza T, Oppelt W, Cortese S, diZerega GS, Berg RA.

Spine J. 2003 Jul-Aug;3(4):277-83; discussion 284.

PMID:
14589186
36.

Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice.

Ellefson DD, diZerega GS, Espinoza T, Roda N, Maldonado S, Rodgers KE.

Cancer Chemother Pharmacol. 2004 Jan;53(1):15-24. Epub 2003 Oct 16.

PMID:
14569417
37.
38.

Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7).

Rodgers KE, Espinoza T, Felix J, Roda N, Maldonado S, diZerega G.

Plast Reconstr Surg. 2003 Mar;111(3):1195-206.

PMID:
12621191
39.

Accelerated recovery from irradiation injury by angiotensin peptides.

Rodgers KE, Xiong S, diZerega GS.

Cancer Chemother Pharmacol. 2002 May;49(5):403-11. Epub 2002 Mar 7.

PMID:
11976835
40.

Effect of angiotensin II on hematopoietic progenitor cell proliferation.

Rodgers KE, Xiong S, Steer R, diZerega GS.

Stem Cells. 2000;18(4):287-94.

41.

Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: pre-clinical studies.

Verco SJ, Peers EM, Brown CB, Rodgers KE, Roda N, diZerega G.

Hum Reprod. 2000 Aug;15(8):1764-72.

PMID:
10920100
42.

Effect of oxiplex* films (PEO/CMC) on adhesion formation and reformation in rabbit models and on peritoneal infection in a rat model.

Rodgers KE, Schwartz HE, Roda N, Thornton M, Kobak W, diZerega GS.

Fertil Steril. 2000 Apr;73(4):831-8.

PMID:
10731549
43.

Reduction of retrosternal and pericardial adhesions with rapidly resorbable polymer films.

Okuyama N, Wang CY, Rose EA, Rodgers KE, Pines E, diZerega GS, Oz MC.

Ann Thorac Surg. 1999 Sep;68(3):913-8.

PMID:
10509983
44.

Symposium overview: alterations in cytokine receptors by xenobiotics.

Cohen MD, Schook LB, Oppenheim JJ, Freed BM, Rodgers KE.

Toxicol Sci. 1999 Apr;48(2):163-9.

PMID:
10353307
45.

Reduction of adhesion formation by intraperitoneal administration of Arg-Gly-Asp-containing peptides.

Rodgers KE, Girgis W, Campeau J, diZerega GS.

Fertil Steril. 1998 Dec;70(6):1131-8.

PMID:
9848306
46.

Reduction of adhesion formation by intraperitoneal administration of various anti-inflammatory agents.

Rodgers KE, Girgis W, St Amand K, Campeau JD, diZerega GS.

J Invest Surg. 1998 Sep-Oct;11(5):327-39.

PMID:
9827650
47.

Reduction of adhesion formation in rabbits by intraperitoneal administration of lazaroid formulations.

Rodgers KE, Girgis W, St Amand K, Campeau J, diZerega GS.

Hum Reprod. 1998 Sep;13(9):2443-51.

PMID:
9806265
48.

Prevention of retrosternal adhesion formation in a rabbit model using bioresorbable films of polyethylene glycol and polylactic acid.

Okuyama N, Rodgers KE, Wang CY, Girgis W, Oz M, St Amand K, Pines E, DeCherney AH, Rose EA, Cohn D, diZerega GS.

J Surg Res. 1998 Aug;78(2):118-22.

PMID:
9733628
49.

Prevention of adhesion formation with intraperitoneal administration of tolmetin and hyaluronic acid.

Rodgers KE, Johns DB, Girgis W, diZerega GS.

J Invest Surg. 1997 Nov-Dec;10(6):367-73.

PMID:
9654393
50.

Histologic alterations in dermal repair after thermal injury effects of topical angiotensin II.

Rodgers KE, DeCherney AH, St Amand KM, Dougherty WR, Felix JC, Girgis WW, diZerega GS.

J Burn Care Rehabil. 1997 Sep-Oct;18(5):381-8.

PMID:
9313116

Supplemental Content

Loading ...
Support Center